Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study

Frontiers in Medicine

Skye McKennon¹ 

关键词: mindfulness;    depression;    drug-resistant;    mobile health;    digital health;    yoga;    telemedicine;    self-care;    disease self-management;   

DOI  :  10.3389/fmed.2017.00037

学科分类：医学（综合）

来源: Frontiers

【 摘 要 】

Recently, the American College of Physicians published clinical practice guidelines recommending yoga and other non-pharmacological modalities as non-invasive therapies for patients with back pain (1). Whether for back pain, depressive symptoms, or other chronic disorders, can we imagine doctors prescribing “breathing” and “yoga” together with pharmacotherapies? The answer may be forthcoming. An article by Sharma et al. (2) on non-pharmacological treatment of drug-resistant depression is a welcoming addition to growing clinical research on adjunct therapies where pharmaceutical drugs may produce inadequate responses. Developing adjunct therapies that incorporate non-pharmacological and self-management practices offers means not only to improve therapy outcomes but also to maintain health-related quality of life after reaching remission. Since chronically ill patients, caregivers, and health-care providers embrace challenges of refractory medical conditions, medication non-adherence, and increasing treatment costs, clinical findings related to the drug-resistant depression described in Sharma et al. (2) have a broader impact on treatments of chronic diseases.

【 授权许可】

CC BY